NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Teriflunomide Observational Effectiveness Study

CompletedN/A

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Teriflunomide

Countries: Canada

The main goal of this investigator-initiated study is to evaluate the effectiveness and efficacy of Teriflunomide in a population of Relapsing Remitting Multiple Sclerosis (RRMS) patients treated in regular practice, over a period of at least two years, in the regular setting of a Multiple Sclerosis Clinic.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Consenting Relapsing Remitting Multiple Sclerosis adults with an Expanded Disability Status Scale (EDSS) score ≤ 5.0 who have been prescribed Teriflunomide and who agree to follow study procedures.

Exclusion Criteria:

* Primary progressive or secondary progressive Multiple Sclerosis without relapses; other diseases that may confound evaluation of outcomes; other exclusion as per product monograph; and women contemplating pregnancy or actually pregnant.

Locations (1)

Montreal, Quebec, Canada